Recent items - Diabetes Research and Clinical Practice
Impact of diabetes and hypertension on left ventricular longitudinal systolic function.
09/09/2010 18:57
Impact of diabetes and hypertension on left ventricular longitudinal systolic function. Diabetes Res Clin Pract. 2010 Sep 3; Authors: Ballo P, Cameli M, Mondillo S, Giacomin E, Lisi M, Padeletti M, Bocelli A, Galderisi M BACKGROUND: The assessment of the longitudinal component of left ventricular (LV) function is of major clinical importance for the early detection of LV contractile impairment. The aim of this study was to compare the impact of isolated type-2 [...]
09/09/2010 18:57
Impact of diabetes and hypertension on left ventricular longitudinal systolic function. Diabetes Res Clin Pract. 2010 Sep 3; Authors: Ballo P, Cameli M, Mondillo S, Giacomin E, Lisi M, Padeletti M, Bocelli A, Galderisi M BACKGROUND: The assessment of the longitudinal component of left ventricular (LV) function is of major clinical importance for the early detection of LV contractile impairment. The aim of this study was to compare the impact of isolated type-2 [...]
Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: A systematic review.
09/09/2010 18:57
Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: A systematic review. Diabetes Res Clin Pract. 2010 Sep 3; Authors: Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Esposito K We conducted a systematic review of randomized controlled trials that evaluated the effectiveness of insulin regimens (basal, biphasic, prandial, and basal-bolus) with insulin analogues to reach the haemoglobin A1c target of <7% in [...]
09/09/2010 18:57
Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: A systematic review. Diabetes Res Clin Pract. 2010 Sep 3; Authors: Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Esposito K We conducted a systematic review of randomized controlled trials that evaluated the effectiveness of insulin regimens (basal, biphasic, prandial, and basal-bolus) with insulin analogues to reach the haemoglobin A1c target of <7% in [...]
Diabetes and sleep: A complex cause-and-effect relationship.
03/09/2010 16:54
Related Articles Diabetes and sleep: A complex cause-and-effect relationship. Diabetes Res Clin Pract. 2010 Aug 30; Authors: Barone MT, Menna-Barreto L Strong associations of diabetes with sleep impairment have been frequently reported. In the present review, we discuss current evidence and hypotheses for how type 1 and type 2 diabetes mellitus are associated with sleep impairment. This association may be described as a vicious circle, where sleep disorders fav [...]
03/09/2010 16:54
Related Articles Diabetes and sleep: A complex cause-and-effect relationship. Diabetes Res Clin Pract. 2010 Aug 30; Authors: Barone MT, Menna-Barreto L Strong associations of diabetes with sleep impairment have been frequently reported. In the present review, we discuss current evidence and hypotheses for how type 1 and type 2 diabetes mellitus are associated with sleep impairment. This association may be described as a vicious circle, where sleep disorders fav [...]
Fulminant type 1 diabetes mellitus with rhabdomyolysis: Have we overlooked the situation?
31/08/2010 20:45
Related Articles Fulminant type 1 diabetes mellitus with rhabdomyolysis: Have we overlooked the situation? Diabetes Res Clin Pract. 2010 Aug 25; Authors: Huang Z, Xu L, Li F, Deng W, Li Y Fulminant type 1 diabetes mellitus (FT1DM) is characterized as remarkably abrupt onset and severe metabolic disorder. Prominent derangement of serum electrolytes was frequently observed, which could be associated with rhabdomyolysis. But the issue was not touched upon in most [...]
31/08/2010 20:45
Related Articles Fulminant type 1 diabetes mellitus with rhabdomyolysis: Have we overlooked the situation? Diabetes Res Clin Pract. 2010 Aug 25; Authors: Huang Z, Xu L, Li F, Deng W, Li Y Fulminant type 1 diabetes mellitus (FT1DM) is characterized as remarkably abrupt onset and severe metabolic disorder. Prominent derangement of serum electrolytes was frequently observed, which could be associated with rhabdomyolysis. But the issue was not touched upon in most [...]
Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus.
25/08/2010 16:45
Related Articles Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus. Diabetes Res Clin Pract. 2010 Aug 20; Authors: Jones DA, Prior SL, Tang TS, Bain SC, Hurel SJ, Humphries SE, Stephens JW Mitochondrial superoxide dismutase 2 (SOD2) is an endogenous anti-oxidant enzyme. The rs4880 gene variant results in a C>T substitution, influencing SOD enzymatic activity. This variant has been asso [...]
25/08/2010 16:45
Related Articles Association between the rs4880 superoxide dismutase 2 (C>T) gene variant and coronary heart disease in diabetes mellitus. Diabetes Res Clin Pract. 2010 Aug 20; Authors: Jones DA, Prior SL, Tang TS, Bain SC, Hurel SJ, Humphries SE, Stephens JW Mitochondrial superoxide dismutase 2 (SOD2) is an endogenous anti-oxidant enzyme. The rs4880 gene variant results in a C>T substitution, influencing SOD enzymatic activity. This variant has been asso [...]
No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects.
25/08/2010 16:45
Related Articles No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects. Diabetes Res Clin Pract. 2010 Aug 19; Authors: Fallah S, Jafarzadeh M, Hedayati M INTRODUCTION: Diabetes mellitus incidence has an increasing rate and it's genetic aspect is an important approach as a risk factor and predictive value in this disorder. In some population, SUMO4, a regulator of NF-kappaB, gene polymorphism is associated with diabetes. A [...]
25/08/2010 16:45
Related Articles No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects. Diabetes Res Clin Pract. 2010 Aug 19; Authors: Fallah S, Jafarzadeh M, Hedayati M INTRODUCTION: Diabetes mellitus incidence has an increasing rate and it's genetic aspect is an important approach as a risk factor and predictive value in this disorder. In some population, SUMO4, a regulator of NF-kappaB, gene polymorphism is associated with diabetes. A [...]
Clinical approach to the patient with diabetes mellitus and very high insulin requirements.
22/08/2010 12:51
Related Articles Clinical approach to the patient with diabetes mellitus and very high insulin requirements. Diabetes Res Clin Pract. 2010 Aug 17; Authors: Ovalle F A number of patients with diabetes require very high (>2Ukg(-1)day(-1)), or extremely high (>3Ukg(-1)day(-1)), insulin doses for the management of their hyperglycemia. Unfortunately, many of the physicians who treat these patients limit themselves to prescribing ever higher doses of insulin, w [...]
22/08/2010 12:51
Related Articles Clinical approach to the patient with diabetes mellitus and very high insulin requirements. Diabetes Res Clin Pract. 2010 Aug 17; Authors: Ovalle F A number of patients with diabetes require very high (>2Ukg(-1)day(-1)), or extremely high (>3Ukg(-1)day(-1)), insulin doses for the management of their hyperglycemia. Unfortunately, many of the physicians who treat these patients limit themselves to prescribing ever higher doses of insulin, w [...]
Clinical determinants of aspirin resistance in diabetes.
22/08/2010 12:51
Related Articles Clinical determinants of aspirin resistance in diabetes. Diabetes Res Clin Pract. 2010 Aug 16; Authors: Yassine HN, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF Recent studies indicate that not all diabetic subjects benefit from aspirin therapy. Our objective is to characterize diabetic subjects with aspirin resistance using urine thromboxane, and VerifyNow measures. Our results suggest that cardiovascular disease, microalbumi [...]
22/08/2010 12:51
Related Articles Clinical determinants of aspirin resistance in diabetes. Diabetes Res Clin Pract. 2010 Aug 16; Authors: Yassine HN, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF Recent studies indicate that not all diabetic subjects benefit from aspirin therapy. Our objective is to characterize diabetic subjects with aspirin resistance using urine thromboxane, and VerifyNow measures. Our results suggest that cardiovascular disease, microalbumi [...]
The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice.
18/08/2010 15:47
Related Articles The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice. Diabetes Res Clin Pract. 2010 May;88 Suppl 1:S11-6 Authors: Shah SN, Litwak L, Haddad J, Chakkarwar PN, Hajjaji I While evidenced-based guidelines promote glycated hemoglobin (HbA(1c)) targets <7.0% in order to reduce the long-term risk of diabetic complications, many individuals with ty [...]
18/08/2010 15:47
Related Articles The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice. Diabetes Res Clin Pract. 2010 May;88 Suppl 1:S11-6 Authors: Shah SN, Litwak L, Haddad J, Chakkarwar PN, Hajjaji I While evidenced-based guidelines promote glycated hemoglobin (HbA(1c)) targets <7.0% in order to reduce the long-term risk of diabetic complications, many individuals with ty [...]
How can observational trials inform and improve clinical practice?
18/08/2010 15:47
Related Articles How can observational trials inform and improve clinical practice? Diabetes Res Clin Pract. 2010 May;88 Suppl 1:S1-2 Authors: Home PD PMID: 20466162 [PubMed - indexed for MEDLINE]
18/08/2010 15:47
Related Articles How can observational trials inform and improve clinical practice? Diabetes Res Clin Pract. 2010 May;88 Suppl 1:S1-2 Authors: Home PD PMID: 20466162 [PubMed - indexed for MEDLINE]
Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations?
18/08/2010 15:47
Related Articles Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations? Diabetes Res Clin Pract. 2010 May;88 Suppl 1:S17-22 Authors: Baik S, Chacra AR, Yuxiu L, White J, Güler S, Latif ZA In low- and middle-income countries, the high personal and economic burden of type 2 diabetes is further compounded by inadequate resources for diabete [...]
18/08/2010 15:47
Related Articles Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations? Diabetes Res Clin Pract. 2010 May;88 Suppl 1:S17-22 Authors: Baik S, Chacra AR, Yuxiu L, White J, Güler S, Latif ZA In low- and middle-income countries, the high personal and economic burden of type 2 diabetes is further compounded by inadequate resources for diabete [...]
DPP-4 inhibitors: What may be the clinical differentiators?
17/08/2010 13:35
Related Articles DPP-4 inhibitors: What may be the clinical differentiators? Diabetes Res Clin Pract. 2010 Aug 12; Authors: Gerich J Attenuation of the prandial incretin effect, mediated by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), contributes to hyperglycemia in type 2 diabetes mellitus (T2DM). Since the launch of sitagliptin in 2006, a compelling body of evidence has accumulated showing that dipeptidyl peptidase-4 (DP [...]
17/08/2010 13:35
Related Articles DPP-4 inhibitors: What may be the clinical differentiators? Diabetes Res Clin Pract. 2010 Aug 12; Authors: Gerich J Attenuation of the prandial incretin effect, mediated by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), contributes to hyperglycemia in type 2 diabetes mellitus (T2DM). Since the launch of sitagliptin in 2006, a compelling body of evidence has accumulated showing that dipeptidyl peptidase-4 (DP [...]
Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease.
17/08/2010 13:35
Related Articles Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease. Diabetes Res Clin Pract. 2010 Aug 12; Authors: Hayashino Y, Fukuhara S, Akizawa T, Asano Y, Wakita T, Onishi Y, Kurokawa K, AIMS: AST-120, an oral adsorbent currently on-label only in Asian countries with phase III trials ongoing in the US, slows renal disease progression in patients with diabetes and advanced-stage c [...]
17/08/2010 13:35
Related Articles Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease. Diabetes Res Clin Pract. 2010 Aug 12; Authors: Hayashino Y, Fukuhara S, Akizawa T, Asano Y, Wakita T, Onishi Y, Kurokawa K, AIMS: AST-120, an oral adsorbent currently on-label only in Asian countries with phase III trials ongoing in the US, slows renal disease progression in patients with diabetes and advanced-stage c [...]
(Diabetes) AND (Diabetes Research and Clinical Practice[Jour]); +16 new citations
14/08/2010 17:27
16 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: (Diabetes) AND (Diabetes Research and Clinical Practice[Jour]) These pubmed results were generated on 2010/08/14PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing f [...]
14/08/2010 17:27
16 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: (Diabetes) AND (Diabetes Research and Clinical Practice[Jour]) These pubmed results were generated on 2010/08/14PubMed, a service of the National Library of Medicine, includes over 15 million citations for biomedical articles back to the 1950's. These citations are from MEDLINE and additional life science journals. PubMed includes links to many sites providing f [...]
Increased red cell count in diabetes and pre-diabetes.
13/08/2010 17:03
Related Articles Increased red cell count in diabetes and pre-diabetes. Diabetes Res Clin Pract. 2010 Aug 9; Authors: Simmons D The aim of this study was to test whether an increased red cell count (RCC) is present in pre-diabetes, obesity and the metabolic syndrome. The results demonstrate that these diabetes precursor states are associated with an increased RCC. This relationship can be explained, in part, by an increased HbA1c. PMID: 20701991 [PubMed [...]
13/08/2010 17:03
Related Articles Increased red cell count in diabetes and pre-diabetes. Diabetes Res Clin Pract. 2010 Aug 9; Authors: Simmons D The aim of this study was to test whether an increased red cell count (RCC) is present in pre-diabetes, obesity and the metabolic syndrome. The results demonstrate that these diabetes precursor states are associated with an increased RCC. This relationship can be explained, in part, by an increased HbA1c. PMID: 20701991 [PubMed [...]
The association between quality of life, depressive symptoms and glycemic control in a group of type 2 diabetes patients.
11/08/2010 20:55
Related Articles The association between quality of life, depressive symptoms and glycemic control in a group of type 2 diabetes patients. Diabetes Res Clin Pract. 2010 Sep;89(3):227-230 Authors: Papelbaum M, Lemos HM, Duchesne M, Kupfer R, Moreira RO, Coutinho WF AIMS: Several studies have demonstrated worse perception of quality of life (QoL) among patients with type 2 diabetes mellitus (T2DM). The purpose of our study was to assess QoL in a clinical sample o [...]
11/08/2010 20:55
Related Articles The association between quality of life, depressive symptoms and glycemic control in a group of type 2 diabetes patients. Diabetes Res Clin Pract. 2010 Sep;89(3):227-230 Authors: Papelbaum M, Lemos HM, Duchesne M, Kupfer R, Moreira RO, Coutinho WF AIMS: Several studies have demonstrated worse perception of quality of life (QoL) among patients with type 2 diabetes mellitus (T2DM). The purpose of our study was to assess QoL in a clinical sample o [...]
Targeting educational interventions to clinician's stage of change.
11/08/2010 20:55
Related Articles Targeting educational interventions to clinician's stage of change. Diabetes Res Clin Pract. 2010 Sep;89(3):e43-e45 Authors: Yu CH, Batty HP This before-after mixed-method study assessed the effect of a diabetes education and self-efficacy training workshop on clinician knowledge, intention and self-efficacy. This workshop demonstrated and narrowed a knowledge gap but did not change intention or self-efficacy. Neither the intervention nor the m [...]
11/08/2010 20:55
Related Articles Targeting educational interventions to clinician's stage of change. Diabetes Res Clin Pract. 2010 Sep;89(3):e43-e45 Authors: Yu CH, Batty HP This before-after mixed-method study assessed the effect of a diabetes education and self-efficacy training workshop on clinician knowledge, intention and self-efficacy. This workshop demonstrated and narrowed a knowledge gap but did not change intention or self-efficacy. Neither the intervention nor the m [...]
Follow-up survey of all participants at the first and second juvenile diabetes summer camp in Japan in 1963 and 1964.
11/08/2010 20:55
Related Articles Follow-up survey of all participants at the first and second juvenile diabetes summer camp in Japan in 1963 and 1964. Diabetes Res Clin Pract. 2010 Sep;89(3):e41-e42 Authors: Otani T, Uchigata Y, Kasahara T, Takaike H, Maruyama H, Iwamoto Y This report documents the status of all 10 participants in the first (1963) and second (1964) summer camp in Japan as of 31 December 2008. The eight living participants continue to function as adults in soci [...]
11/08/2010 20:55
Related Articles Follow-up survey of all participants at the first and second juvenile diabetes summer camp in Japan in 1963 and 1964. Diabetes Res Clin Pract. 2010 Sep;89(3):e41-e42 Authors: Otani T, Uchigata Y, Kasahara T, Takaike H, Maruyama H, Iwamoto Y This report documents the status of all 10 participants in the first (1963) and second (1964) summer camp in Japan as of 31 December 2008. The eight living participants continue to function as adults in soci [...]
IDF: putting women and diabetes on the global agenda.
07/08/2010 14:15
IDF: putting women and diabetes on the global agenda. Diabetes Res Clin Pract. 2010 Aug;89(2):196-9 Authors: Keeling A, Dain K PMID: 20690204 [PubMed - in process]
07/08/2010 14:15
IDF: putting women and diabetes on the global agenda. Diabetes Res Clin Pract. 2010 Aug;89(2):196-9 Authors: Keeling A, Dain K PMID: 20690204 [PubMed - in process]
Aspirin for people with diabetes: A misleading inference in a recent meta-analysis?
03/08/2010 18:47
Related Articles Aspirin for people with diabetes: A misleading inference in a recent meta-analysis? Diabetes Res Clin Pract. 2010 Jul 30; Authors: Martin-Carrillo P, Añino A, Pinar O, Fernandez I, Saenz A, Ausejo M PMID: 20675004 [PubMed - as supplied by publisher]
03/08/2010 18:47
Related Articles Aspirin for people with diabetes: A misleading inference in a recent meta-analysis? Diabetes Res Clin Pract. 2010 Jul 30; Authors: Martin-Carrillo P, Añino A, Pinar O, Fernandez I, Saenz A, Ausejo M PMID: 20675004 [PubMed - as supplied by publisher]
Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit.
03/08/2010 18:47
Related Articles Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit. Diabetes Res Clin Pract. 2010 Jul 29; Authors: Ertorer ME, Haydardedeoglu FE, Erol T, Anaforoglu I, Binici S, Tutuncu NB, Sezgin A, Demirag NG AIMS: To determine prevalence of newly diagnosed hyperglycemia (NDH) among patients with acute coronary disease, inquire relationship of stress hyperglycemia (SH) with functional outcomes. METHODS: Admission (APG) a [...]
03/08/2010 18:47
Related Articles Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit. Diabetes Res Clin Pract. 2010 Jul 29; Authors: Ertorer ME, Haydardedeoglu FE, Erol T, Anaforoglu I, Binici S, Tutuncu NB, Sezgin A, Demirag NG AIMS: To determine prevalence of newly diagnosed hyperglycemia (NDH) among patients with acute coronary disease, inquire relationship of stress hyperglycemia (SH) with functional outcomes. METHODS: Admission (APG) a [...]
Depression and hemoglobin A1c in type 1 and type 2 diabetes: The role of self-efficacy.
03/08/2010 18:47
Related Articles Depression and hemoglobin A1c in type 1 and type 2 diabetes: The role of self-efficacy. Diabetes Res Clin Pract. 2010 Jul 27; Authors: Sacco WP, Bykowski CA AIMS: To examine a self-efficacy explanation of the finding that depression is related to hemoglobin A1c (A1c) level in people with type 1 but not type 2 diabetes. METHODS: Cross-sectional design involving 124 participants with type 1 (n=32) and type 2 (n=92) diabetes. Participants complete [...]
03/08/2010 18:47
Related Articles Depression and hemoglobin A1c in type 1 and type 2 diabetes: The role of self-efficacy. Diabetes Res Clin Pract. 2010 Jul 27; Authors: Sacco WP, Bykowski CA AIMS: To examine a self-efficacy explanation of the finding that depression is related to hemoglobin A1c (A1c) level in people with type 1 but not type 2 diabetes. METHODS: Cross-sectional design involving 124 participants with type 1 (n=32) and type 2 (n=92) diabetes. Participants complete [...]
Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells.
30/07/2010 14:27
Related Articles Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells. Diabetes Res Clin Pract. 2010 Jul 26; Authors: Saitoh Y, Hongwei W, Ueno H, Mizuta M, Nakazato M Angiotensin II receptor blockers (ARBs) have been shown to decrease insulin resistance in obese diabetic animal models and reduce the risk of new-onset diabetes in hypertensive patients. In the present study, we studied whether candesart [...]
30/07/2010 14:27
Related Articles Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic beta-cells. Diabetes Res Clin Pract. 2010 Jul 26; Authors: Saitoh Y, Hongwei W, Ueno H, Mizuta M, Nakazato M Angiotensin II receptor blockers (ARBs) have been shown to decrease insulin resistance in obese diabetic animal models and reduce the risk of new-onset diabetes in hypertensive patients. In the present study, we studied whether candesart [...]
Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials.
27/07/2010 14:04
Related Articles Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials. Diabetes Res Clin Pract. 2010 Jul 22; Authors: Baker MK, Simpson K, Lloyd B, Bauman AE, Singh MA The worldwide epidemic of type 2 diabetes (T2D) emphasizes the need for guidelines regarding community implementation of lifestyle modification prevention programs. An understanding of effective behavioral strategies is needed if evidence tran [...]
27/07/2010 14:04
Related Articles Behavioral strategies in diabetes prevention programs: A systematic review of randomized controlled trials. Diabetes Res Clin Pract. 2010 Jul 22; Authors: Baker MK, Simpson K, Lloyd B, Bauman AE, Singh MA The worldwide epidemic of type 2 diabetes (T2D) emphasizes the need for guidelines regarding community implementation of lifestyle modification prevention programs. An understanding of effective behavioral strategies is needed if evidence tran [...]
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: A retrospective analysis of the GALIANT study.
27/07/2010 14:04
Related Articles Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: A retrospective analysis of the GALIANT study. Diabetes Res Clin Pract. 2010 Jul 22; Authors: Banerji MA, Purkayastha D, Francis BH OBJECTIVE: This retrospective analysis assessed safety and tolerability of vildagliptin (Vilda) as an add-on to metformin in type 2 diabetes mellitus (T2DM) patien [...]
27/07/2010 14:04
Related Articles Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: A retrospective analysis of the GALIANT study. Diabetes Res Clin Pract. 2010 Jul 22; Authors: Banerji MA, Purkayastha D, Francis BH OBJECTIVE: This retrospective analysis assessed safety and tolerability of vildagliptin (Vilda) as an add-on to metformin in type 2 diabetes mellitus (T2DM) patien [...]
Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes.
27/07/2010 14:04
Related Articles Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Res Clin Pract. 2010 Jul 22; Authors: Kong W, Langlois MF, Kamga-Ngandé C, Gagnon C, Brown C, Baillargeon JP This study aimed at identifying predictors of success (retention after one year of intervention with >/=5% weight loss) in subjects at high risk for type 2 diabetes enrolled in a lifestyle modification program. Fifty-on [...]
27/07/2010 14:04
Related Articles Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Res Clin Pract. 2010 Jul 22; Authors: Kong W, Langlois MF, Kamga-Ngandé C, Gagnon C, Brown C, Baillargeon JP This study aimed at identifying predictors of success (retention after one year of intervention with >/=5% weight loss) in subjects at high risk for type 2 diabetes enrolled in a lifestyle modification program. Fifty-on [...]
The clinical use of the 10g monofilament and its limitations: A review.
27/07/2010 14:04
Related Articles The clinical use of the 10g monofilament and its limitations: A review. Diabetes Res Clin Pract. 2010 Jul 21; Authors: Tan LS BACKGROUND: Diabetes mellitus is one of the most prevalent chronic diseases worldwide including Singapore. The 10g monofilament is commonly used by clinicians to examine diabetic patients for neuropathy due to its low cost and convenience. The aim of this literature review is to evaluate the use of the monofilament and t [...]
27/07/2010 14:04
Related Articles The clinical use of the 10g monofilament and its limitations: A review. Diabetes Res Clin Pract. 2010 Jul 21; Authors: Tan LS BACKGROUND: Diabetes mellitus is one of the most prevalent chronic diseases worldwide including Singapore. The 10g monofilament is commonly used by clinicians to examine diabetic patients for neuropathy due to its low cost and convenience. The aim of this literature review is to evaluate the use of the monofilament and t [...]